Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06786468

Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Randomized Controlled Trial of Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.

Detailed description

Advanced non-small cell lung cancer patients initiating a systemic treatment will be randomized to the early palliative care arm (attending a palliative care clinic once a month during the first three months concurrently with oncology clinic appointment) or the standard care arm (attending oncology clinic only). The patients will be asked to complete the quality of life questionnaires (FACT-L, EQ-5D-5L), mental health questionnaire (PHQ-9), and pain assessment once a month for three months and at the sixth month.

Conditions

Interventions

TypeNameDescription
OTHEREarly palliative care integrationThe patients will attend palliative care clinic once a month during the first three months together with routine oncology clinic visits
DRUGStandard systemic treatment for advanced lung cancerStandard systemic treatment for advanced lung cancer

Timeline

Start date
2024-04-02
Primary completion
2026-04-01
Completion
2027-04-01
First posted
2025-01-22
Last updated
2025-01-22

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06786468. Inclusion in this directory is not an endorsement.